Thyroid RFA offers a scar-free solution to symptoms such as difficulty swallowing, discomfort, and cosmetic concerns. Clinical studies show that patients can experience up to an 80% reduction in nodule size within a year, all without the risks associated with surgery or the need for lifelong hormone therapy.
"Since introducing RFA, I've seen how it provides patients with excellent results while avoiding surgery," says Dr. Grady. "With minimal downtime and expanding insurance coverage, this treatment is a game-changer for thyroid care."
Additionally, insurance coverage is now available for Thyroid RFA, making this treatment more accessible to patients. Coverage varies based on individual insurance plans, and patients are encouraged to check with their provider regarding eligibility.
The in-office procedure is performed under local anesthesia, typically lasting 30–60 minutes, depending on the size of the nodule. Patients remain under observation for an additional 60–120 minutes before discharge. Dr. Grady uses STARmed's industry-leading RF technology to ensure the highest standard of care with the most clinically proven system. STARmed RF System is the only RF technology featured in over 80% of all thyroid RFA clinical studies, demonstrating its unmatched safety and efficacy in treating benign thyroid nodules.
About Portland Diabetes & Endocrinology Center:
Founded in the 1920s, Portland Diabetes & Endocrinology Center (PDEC) is one of the largest and most established private endocrinology clinics in the United States. PDEC has been a pioneer in research and innovation for the treatment of endocrine disorders, continuously advancing patient care in diabetes, thyroid conditions, and metabolic diseases.
